ArticleAnti-cancer drugs2020

Dexmedetomidine suppresses the progression of esophageal cancer via miR-143-3p/epidermal growth factor receptor pathway substrate 8 axis.

Peisen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.